Abraxane 100 MG Injection

RxCUI
583218
RxNorm name
Abraxane 100 MG Injection
Display name
Abraxane 100 MG Injection
Full name
Abraxane 100 MG Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ABRAXANEPACLITAXELAbraxis BioScience, LLC24d10449-2936-4cd3-b7db-a7683db721e42022-10-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 583218

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
24d10449-2936-4cd3-b7db-a7683db721e4Abraxane 100 MG InjectionSY37These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE. ABRAXANE ® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound), for intravenous use Initial U.S. Approval: 200520221031
24d10449-2936-4cd3-b7db-a7683db721e4Abraxane 100 MG InjectionPSN37These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE. ABRAXANE ® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound), for intravenous use Initial U.S. Approval: 200520221031
24d10449-2936-4cd3-b7db-a7683db721e4paclitaxel 100 MG Injection [Abraxane]SBD37These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE. ABRAXANE ® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound), for intravenous use Initial U.S. Approval: 200520221031